ERIS LIFESCIENCES
Back to Balance Sheet
|
ERIS LIFESCIENCES Last 5 Year Total Current Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Current Liabilities | ₹2,609 Cr | ₹521 Cr | ₹283 Cr | ₹235 Cr | ₹220 Cr |
What is the latest Total Current Liabilities ratio of ERIS LIFESCIENCES ?
Year | Total Current Liabilities |
---|---|
Mar2024 | ₹2,609 Cr |
Mar2023 | ₹521 Cr |
Mar2022 | ₹283 Cr |
Mar2021 | ₹235 Cr |
Mar2020 | ₹220 Cr |
How is Total Current Liabilities of ERIS LIFESCIENCES Trending?
Years | Total Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹2,609 Cr | 400.58 | |
Mar2023 | ₹521 Cr | 83.94 | |
Mar2022 | ₹283 Cr | 20.34 | |
Mar2021 | ₹235 Cr | 6.94 | |
Mar2020 | ₹220 Cr | - |
Compare Total Current Liabilities of peers of ERIS LIFESCIENCES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ERIS LIFESCIENCES | ₹17,435.8 Cr | 1.3% | 3.4% | 45.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹402,608.0 Cr | -3.9% | -6.7% | 11.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹157,383.0 Cr | -1.4% | 1.8% | 56.7% | Stock Analytics | |
CIPLA | ₹118,239.0 Cr | -0.6% | 1.7% | 0.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹97,187.7 Cr | -4.8% | -10.2% | -6.6% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹89,695.7 Cr | -5.4% | -8.9% | 0.6% | Stock Analytics |
ERIS LIFESCIENCES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ERIS LIFESCIENCES | 1.3% |
3.4% |
45.2% |
SENSEX | -0.3% |
0.1% |
4.9% |
You may also like the below Video Courses